Category: Trial Briefs
Noninvasive tests replace biopsies for liver disease diagnosis
Noninvasive tests now replace risky liver biopsies for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and MASLD,...
Dermatology Society Urges New Tests for Stubborn Eczema
Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors...
New AAN AHS Guideline Recommends Adult Migraine Prevention
The new American Association of Neurology and American Headache Society guideline outlines migraine preventive pharmacologic...
Early Kidney Disease Diagnosis Rates Stagnant
Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.
Valbenazine Improves Quality of Life in Tardive Dyskinesia
New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.
Dual Therapy Shifts SMA Treatment Landscape
Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments...
Neurology and Headache Societies Release New Migraine Guideline
The American Academy of Neurology and American Headache Society released an updated migraine prevention guideline...
Combined Risk Factors Linked to Late Parkinson Disease
Study reveals combined risk factors significantly increase late-onset Parkinson disease risk, with multiple exposures showing...
Sarkey Highlights Oveporexton Impact on Type 1 Narcolepsy
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn...
Architects of the hunt design deadly strategies
Architects of the hunt design deadly strategies in media regulation. Sign the open letter calling...